EPO-BUL-01 - Study of the Optimization of Anemia Management of EPREX (Epoetin Alfa) in Predialysis Patients With Chronic Renal Failure
Clinical trial NCT00338000 · COMPLETED
Trial details
- NCT number
- NCT00338000
- Sponsor
- Janssen Pharmaceutica N.V., Belgium
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2001-06-01
- Enrollment
- 292
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.